Exact Mass: 775.617315

Exact Mass Matches: 775.617315

Found 214 metabolites which its exact mass value is equals to given mass value 775.617315, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PC(15:0/20:0)

(2-{[(2R)-2-(icosanoyloxy)-3-(pentadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C43H86NO8P (775.6090726)


PC(15:0/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/20:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(15:0/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/20:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(20:0/15:0)

(2-{[(2R)-3-(icosanoyloxy)-2-(pentadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C43H86NO8P (775.6090726)


PC(20:0/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/15:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(20:0/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/15:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(14:0/24:0)

(2-aminoethoxy)[(2R)-2-(tetracosanoyloxy)-3-(tetradecanoyloxy)propoxy]phosphinic acid

C43H86NO8P (775.6090726)


PE(14:0/24:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:0/24:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(14:0/24:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(14:0/24:0), in particular, consists of one tetradecanoyl chain to the C-1 atom, and one tetracosanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(16:0/22:0)

(2-aminoethoxy)[(2R)-2-(docosanoyloxy)-3-(hexadecanoyloxy)propoxy]phosphinic acid

C43H86NO8P (775.6090726)


PE(16:0/22:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:0/22:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of behenic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(16:0/22:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:0/22:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of behenic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(18:0/20:0)

(2-aminoethoxy)[(2R)-2-(icosanoyloxy)-3-(octadecanoyloxy)propoxy]phosphinic acid

C43H86NO8P (775.6090726)


PE(18:0/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/20:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(18:0/20:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(18:0/20:0), in particular, consists of one octadecanoyl chain to the C-1 atom, and one eicosanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(20:0/18:0)

(2-aminoethoxy)[(2R)-3-(icosanoyloxy)-2-(octadecanoyloxy)propoxy]phosphinic acid

C43H86NO8P (775.6090726)


PE(20:0/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:0/18:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of stearic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(20:0/18:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(20:0/18:0), in particular, consists of one eicosanoyl chain to the C-1 atom, and one octadecanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(22:0/16:0)

(2-aminoethoxy)[(2R)-3-(docosanoyloxy)-2-(hexadecanoyloxy)propoxy]phosphinic acid

C43H86NO8P (775.6090726)


PE(22:0/16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:0/16:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(22:0/16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:0/16:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(24:0/14:0)

(2-aminoethoxy)[(2R)-3-(tetracosanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphinic acid

C43H86NO8P (775.6090726)


PE(24:0/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:0/14:0), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of myristic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(24:0/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:0/14:0), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of myristic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(15:0/22:0)

[2-(docosanoyloxy)-3-(pentadecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid

C43H86NO8P (775.6090726)


PE-NMe(15:0/22:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(15:0/22:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(22:0/15:0)

[3-(docosanoyloxy)-2-(pentadecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid

C43H86NO8P (775.6090726)


PE-NMe(22:0/15:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:0/15:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(18:0/18:0)

[2,3-bis(octadecanoyloxy)propoxy][2-(dimethylamino)ethoxy]phosphinic acid

C43H86NO8P (775.6090726)


PE-NMe2(18:0/18:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(18:0/18:0), in particular, consists of two octadecanoyl chain at positions C-1 and C2. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe2(14:0/22:0)

[2-(dimethylamino)ethoxy][2-(docosanoyloxy)-3-(tetradecanoyloxy)propoxy]phosphinic acid

C43H86NO8P (775.6090726)


PE-NMe2(14:0/22:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(14:0/22:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(16:0/20:0)

[2-(dimethylamino)ethoxy][3-(hexadecanoyloxy)-2-(icosanoyloxy)propoxy]phosphinic acid

C43H86NO8P (775.6090726)


PE-NMe2(16:0/20:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(16:0/20:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(20:0/16:0)

[2-(dimethylamino)ethoxy][2-(hexadecanoyloxy)-3-(icosanoyloxy)propoxy]phosphinic acid

C43H86NO8P (775.6090726)


PE-NMe2(20:0/16:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:0/16:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(22:0/14:0)

[2-(dimethylamino)ethoxy][3-(docosanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphinic acid

C43H86NO8P (775.6090726)


PE-NMe2(22:0/14:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:0/14:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PC(16:0/19:0)

(2-{[3-(hexadecanoyloxy)-2-(nonadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C43H86NO8P (775.6090726)


   

Cyanidin 3-O-glucoside

(2-{[(2R)-3-(dodecanoyloxy)-2-(tricosanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C43H86NO8P (775.6090726)


   

Cyanidin 3-O-rutinoside

(2-{[(2R)-2-(docosanoyloxy)-3-(tridecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C43H86NO8P (775.6090726)


   

Cyanidin 3-O-sambubioside

(2-{[(2R)-2-(henicosanoyloxy)-3-(tetradecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C43H86NO8P (775.6090726)


   

Cyanidin 3-O-xyloside

(2-{[(2R)-3-(hexadecanoyloxy)-2-(nonadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C43H86NO8P (775.6090726)


   

dehydrocafestol

(2-{[(2R)-3-(heptadecanoyloxy)-2-(octadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C43H86NO8P (775.6090726)


   

Deoxylactucin (8-)

(2-{[(2R)-2-(hexadecanoyloxy)-3-(nonadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C43H86NO8P (775.6090726)


   

Dopamine-betaxanthin

(2-{[(2R)-3-(docosanoyloxy)-2-(tridecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C43H86NO8P (775.6090726)


   

1-O-beta-D-glucopyranosyl-(2S,3S,4R)-2-[(2R)-2-hydroxynonadecanoylamino]-16-methyl-heptadeca-1,3,4-triol|renieroside C9

1-O-beta-D-glucopyranosyl-(2S,3S,4R)-2-[(2R)-2-hydroxynonadecanoylamino]-16-methyl-heptadeca-1,3,4-triol|renieroside C9

C43H85NO10 (775.617315)


   

PC(13:0/22:0)[U]

3,5,8-Trioxa-4-phosphatriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotridecyl)oxy]methyl]-, inner salt, 4-oxide

C43H86NO8P (775.6090726)


   

PC(14:0/21:0)[U]

3,5,8-Trioxa-4-phosphanonacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotetradecyl)oxy]methyl]-, inner salt, 4-oxide

C43H86NO8P (775.6090726)


   

PC(15:0/20:0)[U]

3,5,8-Trioxa-4-phosphaoctacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxopentadecyl)oxy]methyl]-, inner salt, 4-oxide

C43H86NO8P (775.6090726)


   

PC(16:0/19:0)[U]

3,5,8-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxohexadecyl)oxy]methyl]-, inner salt, 4-oxide

C43H86NO8P (775.6090726)


   

PC(17:0/18:0)

3,5,8-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxoheptadecyl)oxy]methyl]-, inner salt, 4-oxide, (R)-

C43H86NO8P (775.6090726)


   

PC(17:0/18:0)[U]

3,5,8-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxoheptadecyl)oxy]methyl]-, inner salt, 4-oxide

C43H86NO8P (775.6090726)


   

PC(18:0/17:0)[U]

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoheptadecyl)oxy]-, inner salt, 4-oxide

C43H86NO8P (775.6090726)


   

PC(19:0/16:0)[U]

3,5,9-Trioxa-4-phosphaoctacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[[(1-oxohexadecyl)oxy]methyl]-, inner salt, 4-oxide

C43H86NO8P (775.6090726)


   

PC(20:0/15:0)[U]

3,5,9-Trioxa-4-phosphanonacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxopentadecyl)oxy]-, inner salt, 4-oxide

C43H86NO8P (775.6090726)


   

PC(21:0/14:0)

3,5,9-Trioxa-4-phosphatriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotetradecyl)oxy]-, inner salt, 4-oxide, (R)-

C43H86NO8P (775.6090726)


   

PC(22:0/13:0)

3,5,9-Trioxa-4-phosphahentriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotridecyl)oxy]-, inner salt, 4-oxide, (R)-

C43H86NO8P (775.6090726)


   

PC(23:0/12:0)[U]

3,5,9-Trioxa-4-phosphadotriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxododecyl)oxy]-, inner salt, 4-oxide

C43H86NO8P (775.6090726)


   

PC(24:0/11:0)[U]

3,5,9-Trioxa-4-phosphatritriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoundecyl)oxy]-, inner salt, 4-oxide

C43H86NO8P (775.6090726)


   

PE(19:0/19:0)[U]

Nonadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester

C43H86NO8P (775.6090726)


   

PE(18:0/20:0)

Eicosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxooctadecyl)oxy]ethyl ester, (R)-

C43H86NO8P (775.6090726)


   

PE(20:0/18:0)

Eicosanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxooctadecyl)oxy]propyl ester, (R)-

C43H86NO8P (775.6090726)


   

PE(16:0/22:0)

Docosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester, (R)-

C43H86NO8P (775.6090726)


   

PE(18:0/20:0)[U]

Eicosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxooctadecyl)oxy]ethyl ester

C43H86NO8P (775.6090726)


   

PE(16:0/22:0)[U]

Docosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester

C43H86NO8P (775.6090726)


   

PE(22:0/16:0)[U]

1-Docosanoyl-2-hexadecanoyl-sn-glycero-3-phosphoethanolamine

C43H86NO8P (775.6090726)


   

PE(21:0/17:0)[U]

1-heneicosanoyl-2-heptadecanoyl-sn-glycero-3-phosphoethanolamine

C43H86NO8P (775.6090726)


   

PE(17:0/21:0)[U]

1-heptadecanoyl-2-heneicosanoyl-sn-glycero-3-phosphoethanolamine

C43H86NO8P (775.6090726)


   

PE-NMe2(18:0/18:0)

Octadecanoic acid, 1-[[[[2-(dimethylamino)ethoxy]hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, (R)-

C43H86NO8P (775.6090726)


   

GPEtnNMe2(18:0/18:0)[U]

Octadecanoic acid, 1-[[[[2-(dimethylamino)ethoxy]hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester

C43H86NO8P (775.6090726)


   

Lecithin

1-Arachidonyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C43H86NO8P (775.6090726)


   

PE(38:0)

1-lignoceroyl-2-myristoyl-sn-glycero-3-phosphoethanolamine

C43H86NO8P (775.6090726)


   

PC(13:0/22:0)

1-tridecanoyl-2-docosanoyl-glycero-3-phosphocholine

C43H86NO8P (775.6090726)


   

PC(14:0/21:0)

1-tetradecanoyl-2-heneicosanoyl-glycero-3-phosphocholine

C43H86NO8P (775.6090726)


   

PC(16:0/19:0)

1-hexadecanoyl-2-nonadecanoyl-glycero-3-phosphocholine

C43H86NO8P (775.6090726)


   

PC(18:0/17:0)

1-octadecanoyl-2-heptadecanoyl-glycero-3-phosphocholine

C43H86NO8P (775.6090726)


   

PC(19:0/16:0)

1-nonadecanoyl-2-hexadecanoyl-glycero-3-phosphocholine

C43H86NO8P (775.6090726)


   

PE(17:0/21:0)

1-heptadecanoyl-2-heneicosanoyl-glycero-3-phosphoethanolamine

C43H86NO8P (775.6090726)


   

PE(21:0/17:0)

1-heneicosanoyl-2-heptadecanoyl-glycero-3-phosphoethanolamine

C43H86NO8P (775.6090726)


   

PE(19:0/19:0)

1,2-dinonadecanoyl-sn-glycero-3-phosphoethanolamine

C43H86NO8P (775.6090726)


   

PC 35:0

1-heneicosanoyl-2-tetradecanoyl-sn-glycero-3-phosphocholine

C43H86NO8P (775.6090726)


   

PE 38:0

Docosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester, (R)-

C43H86NO8P (775.6090726)


   

PE-NMe2 36:0

Octadecanoic acid, 1-[[[[2-(dimethylamino)ethoxy]hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, (R)-

C43H86NO8P (775.6090726)


   

HexCer 37:0;O4

N-(2R-hydroxyheneicosanoyl)-1-beta-glucopyranosyl-4R-hydroxy-14-methyl-pentadecasphinganine

C43H85NO10 (775.617315)


   

PC(16:0/19:0)

(2-{[3-(hexadecanoyloxy)-2-(nonadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C43H86NO8P (775.6090726)


   

N-(2-hydroxyicosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

N-(2-hydroxyicosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

C43H85NO10 (775.617315)


   

HexCer 17:0;3O/20:0;(2OH)

HexCer 17:0;3O/20:0;(2OH)

C43H85NO10 (775.617315)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] icosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] icosanoate

C43H86NO8P (775.6090726)


   

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-nonadecanoyloxypropyl] nonadecanoate

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-nonadecanoyloxypropyl] nonadecanoate

C43H86NO8P (775.6090726)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

HexCer 9:0;3O/28:0;(2OH)

HexCer 9:0;3O/28:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 8:0;3O/29:0;(2OH)

HexCer 8:0;3O/29:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 10:0;3O/27:0;(2OH)

HexCer 10:0;3O/27:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 12:0;3O/25:0;(2OH)

HexCer 12:0;3O/25:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 13:0;3O/24:0;(2OH)

HexCer 13:0;3O/24:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 11:0;3O/26:0;(2OH)

HexCer 11:0;3O/26:0;(2OH)

C43H85NO10 (775.617315)


   

(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxypentacos-4-ene-1-sulfonic acid

(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxypentacos-4-ene-1-sulfonic acid

C47H85NO5S (775.6148119999999)


   

2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxypentacosane-1-sulfonic acid

2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxypentacosane-1-sulfonic acid

C47H85NO5S (775.6148119999999)


   

(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]tricos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]tricos-4-ene-1-sulfonic acid

C47H85NO5S (775.6148119999999)


   

(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]tricosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]tricosa-4,8,12-triene-1-sulfonic acid

C47H85NO5S (775.6148119999999)


   

(4E,8E,12E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyhexacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyhexacosa-4,8,12-triene-1-sulfonic acid

C47H85NO5S (775.6148119999999)


   

(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxyhenicosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxyhenicosa-4,8-diene-1-sulfonic acid

C47H85NO5S (775.6148119999999)


   

(4E,8E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxypentacosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxypentacosa-4,8-diene-1-sulfonic acid

C47H85NO5S (775.6148119999999)


   

(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]tricosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]tricosa-4,8-diene-1-sulfonic acid

C47H85NO5S (775.6148119999999)


   

2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyhenicosane-1-sulfonic acid

2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyhenicosane-1-sulfonic acid

C47H85NO5S (775.6148119999999)


   

(4E,8E,12E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxypentacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxypentacosa-4,8,12-triene-1-sulfonic acid

C47H85NO5S (775.6148119999999)


   

(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxyhenicos-4-ene-1-sulfonic acid

(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxyhenicos-4-ene-1-sulfonic acid

C47H85NO5S (775.6148119999999)


   

(4E,8E,12E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxyhenicosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxyhenicosa-4,8,12-triene-1-sulfonic acid

C47H85NO5S (775.6148119999999)


   

3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]tricosane-1-sulfonic acid

3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]tricosane-1-sulfonic acid

C47H85NO5S (775.6148119999999)


   

2-[4-[10,13-dimethyl-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

2-[4-[10,13-dimethyl-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C50H81NO5 (775.6114415999999)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] nonacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] nonacosanoate

C43H86NO8P (775.6090726)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] octacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] octacosanoate

C43H86NO8P (775.6090726)


   

Cer 16:0;2O/18:5;(3OH)(FA 16:4)

Cer 16:0;2O/18:5;(3OH)(FA 16:4)

C50H81NO5 (775.6114415999999)


   

Cer 15:0;2O/19:5;(3OH)(FA 16:4)

Cer 15:0;2O/19:5;(3OH)(FA 16:4)

C50H81NO5 (775.6114415999999)


   

Cer 18:0;2O/16:5;(3OH)(FA 16:4)

Cer 18:0;2O/16:5;(3OH)(FA 16:4)

C50H81NO5 (775.6114415999999)


   

Cer 14:0;2O/20:5;(3OH)(FA 16:4)

Cer 14:0;2O/20:5;(3OH)(FA 16:4)

C50H81NO5 (775.6114415999999)


   

Cer 14:0;2O/20:6;(3OH)(FA 16:3)

Cer 14:0;2O/20:6;(3OH)(FA 16:3)

C50H81NO5 (775.6114415999999)


   

Cer 16:0;2O/16:5;(3OH)(FA 18:4)

Cer 16:0;2O/16:5;(3OH)(FA 18:4)

C50H81NO5 (775.6114415999999)


   

Cer 14:0;2O/16:5;(3OH)(FA 20:4)

Cer 14:0;2O/16:5;(3OH)(FA 20:4)

C50H81NO5 (775.6114415999999)


   

Cer 14:0;2O/16:4;(3OH)(FA 20:5)

Cer 14:0;2O/16:4;(3OH)(FA 20:5)

C50H81NO5 (775.6114415999999)


   

Cer 16:0;2O/16:4;(3OH)(FA 18:5)

Cer 16:0;2O/16:4;(3OH)(FA 18:5)

C50H81NO5 (775.6114415999999)


   

Cer 15:0;2O/16:5;(3OH)(FA 19:4)

Cer 15:0;2O/16:5;(3OH)(FA 19:4)

C50H81NO5 (775.6114415999999)


   

Cer 14:0;2O/20:4;(3OH)(FA 16:5)

Cer 14:0;2O/20:4;(3OH)(FA 16:5)

C50H81NO5 (775.6114415999999)


   

Cer 15:0;2O/16:4;(3OH)(FA 19:5)

Cer 15:0;2O/16:4;(3OH)(FA 19:5)

C50H81NO5 (775.6114415999999)


   

Cer 16:0;2O/18:4;(3OH)(FA 16:5)

Cer 16:0;2O/18:4;(3OH)(FA 16:5)

C50H81NO5 (775.6114415999999)


   

Cer 14:0;2O/18:4;(3OH)(FA 18:5)

Cer 14:0;2O/18:4;(3OH)(FA 18:5)

C50H81NO5 (775.6114415999999)


   

Cer 18:0;2O/16:4;(3OH)(FA 16:5)

Cer 18:0;2O/16:4;(3OH)(FA 16:5)

C50H81NO5 (775.6114415999999)


   

Cer 14:0;2O/16:3;(3OH)(FA 20:6)

Cer 14:0;2O/16:3;(3OH)(FA 20:6)

C50H81NO5 (775.6114415999999)


   

Cer 15:0;2O/19:4;(3OH)(FA 16:5)

Cer 15:0;2O/19:4;(3OH)(FA 16:5)

C50H81NO5 (775.6114415999999)


   

Cer 14:0;2O/18:5;(3OH)(FA 18:4)

Cer 14:0;2O/18:5;(3OH)(FA 18:4)

C50H81NO5 (775.6114415999999)


   

HexCer 24:0;3O/13:0;(2OH)

HexCer 24:0;3O/13:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 20:0;3O/17:0;(2OH)

HexCer 20:0;3O/17:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 15:0;3O/22:0;(2OH)

HexCer 15:0;3O/22:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 18:0;3O/19:0;(2OH)

HexCer 18:0;3O/19:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 22:0;3O/15:0;(2OH)

HexCer 22:0;3O/15:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 19:0;3O/18:0;(2OH)

HexCer 19:0;3O/18:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 14:0;3O/23:0;(2OH)

HexCer 14:0;3O/23:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 21:0;3O/16:0;(2OH)

HexCer 21:0;3O/16:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 23:0;3O/14:0;(2OH)

HexCer 23:0;3O/14:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 16:0;3O/21:0;(2OH)

HexCer 16:0;3O/21:0;(2OH)

C43H85NO10 (775.617315)


   

HexCer 25:0;3O/12:0;(2OH)

HexCer 25:0;3O/12:0;(2OH)

C43H85NO10 (775.617315)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] triacontanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] triacontanoate

C43H86NO8P (775.6090726)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] docosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] docosanoate

C43H86NO8P (775.6090726)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] henicosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] henicosanoate

C43H86NO8P (775.6090726)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] tetracosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] tetracosanoate

C43H86NO8P (775.6090726)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] hexacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] hexacosanoate

C43H86NO8P (775.6090726)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] pentacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] pentacosanoate

C43H86NO8P (775.6090726)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] tricosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] tricosanoate

C43H86NO8P (775.6090726)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] heptacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] heptacosanoate

C43H86NO8P (775.6090726)


   

(2-Docosanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Docosanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

(2-Henicosanoyloxy-3-tetradecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Henicosanoyloxy-3-tetradecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

(2-Icosanoyloxy-3-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Icosanoyloxy-3-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

(3-Heptadecanoyloxy-2-octadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Heptadecanoyloxy-2-octadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

(2-Heptacosanoyloxy-3-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Heptacosanoyloxy-3-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

(3-Dodecanoyloxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Dodecanoyloxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

(3-Decanoyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Decanoyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

(2-Hexacosanoyloxy-3-nonanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hexacosanoyloxy-3-nonanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

(2-Tetracosanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Tetracosanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

[(2S)-3-henicosanoyloxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-henicosanoyloxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] tricosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] tricosanoate

C43H86NO8P (775.6090726)


   

[(2R)-2-decanoyloxy-3-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-decanoyloxy-3-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

[(2S)-3-tetracosanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-tetracosanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] tetracosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] tetracosanoate

C43H86NO8P (775.6090726)


   

[(2S)-3-docosanoyloxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-docosanoyloxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] pentacosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] pentacosanoate

C43H86NO8P (775.6090726)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] tricosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] tricosanoate

C43H86NO8P (775.6090726)


   

[(2R)-2-dodecanoyloxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-dodecanoyloxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] pentacosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] pentacosanoate

C43H86NO8P (775.6090726)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] hexacosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] hexacosanoate

C43H86NO8P (775.6090726)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] henicosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] henicosanoate

C43H86NO8P (775.6090726)


   

[(2S)-3-icosanoyloxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-icosanoyloxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H86NO8P (775.6090726)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] docosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] docosanoate

C43H86NO8P (775.6090726)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] hexacosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] hexacosanoate

C43H86NO8P (775.6090726)


   

1-octadecanoyl-2-eicosanoyl-sn-glycero-3-phosphoethanolamine

1-octadecanoyl-2-eicosanoyl-sn-glycero-3-phosphoethanolamine

C43H86NO8P (775.6090726)


   

1-octadecanoyl-2-heptadecanoyl-glycero-3-phosphocholine

1-octadecanoyl-2-heptadecanoyl-glycero-3-phosphocholine

C43H86NO8P (775.6090726)


   

phosphatidylethanolamine 38:0

phosphatidylethanolamine 38:0

C43H86NO8P (775.6090726)


A phosphatidylethanolamine in which the two acyl groups contain a total of 38 carbons and no double bonds.

   

phosphatidylcholine 35:0

phosphatidylcholine 35:0

C43H86NO8P (775.6090726)


A phosphatidylcholine in which the two acyl groups contain a total of 35 carbons and no double bonds.

   

phosphatidylethanolamine 38:0 zwitterion

phosphatidylethanolamine 38:0 zwitterion

C43H86NO8P (775.6090726)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 38 carbons in total with 0 double bonds.

   

MePC(34:0)

MePC(18:0_16:0)

C43H86NO8P (775.6090726)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

dMePE(36:0)

dMePE(20:0_16:0)

C43H86NO8P (775.6090726)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved